The insider selling cluster is too small in dollar terms and involves only directors, not C-suite executives, to warrant a bearish read. Per the academic literature, cluster sales are not more informative than non-cluster sales, and the historical calibration for WVE reports shows the stock has consistently faded bullish/bearish reads. Monitor for any C-suite open-market sales or a material increase in selling volume before adjusting positioning.
Price Chart
Executive Summary
Three Wave Life Sciences directors sold a total of ~$132K in open-market shares over a one-week window, with the largest sale ($67K) occurring on August 12 at $5.29. The cluster is small relative to the $1.0B market cap (~0.013%), and all sellers are non-C-suite directors, which per the academic literature carries weak predictive power for insider sales. Historical reports on WVE have performed very poorly (10% win rate at T+20), suggesting the market has consistently faded bullish reads on this name.
Key Financial Metrics
Key Facts
- Three directors sold a combined ~$132K in open-market shares from Aug 5-12, 2026
- Largest sale: Director Adrian Rawcliffe sold 12,700 shares at $5.29 for $67,183
- Heidi L. Wagner exercised 7,000 derivative shares (non-cash) and simultaneously sold 7,000 shares at $6.01
- Total cluster value of $132K represents ~0.013% of WVE's $1.0B market cap
- No C-suite executives (CEO, CFO, COO) participated in any trades
- Historical WVE reports show a 10% win rate at T+20 with average alpha of -13.54% vs SPY
Financial Impact
$132K in total insider sales, ~0.013% of market cap — immaterial
Risk Factors
- Director sales could precede a broader insider selling trend if C-suite executives follow
- WVE's historical T+20 performance has been poor, suggesting the stock may continue to underperform regardless of this filing
- No positive catalyst identified to offset the selling signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-WVE-1786669361850 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Insider Cluster | $5.41 $4.58 | ▼ −15.34% | ▼ −13.35% | $3.80 (−29.85%) |
May 18, 2026 19w ago | Press Release | $6.14 $5.95 | ▼ −3.09% | ▼ −4.08% | $3.80 (−38.19%) |
Apr 28, 2026 22w ago | 8-K | $7.52 $6.34 | ▼ −15.69% | ▼ −21.15% | $3.80 (−49.53%) |
Apr 28, 2026 22w ago | Press Release | $7.52 $6.38 | ▼ −15.16% | ▼ −20.63% | $3.80 (−49.53%) |
Apr 22, 2026 23w ago | Press Release | $7.38 $6.14 | ▼ −16.80% | ▼ −19.97% | $3.80 (−48.58%) |
Apr 15, 2026 24w ago | DEFA14A | $7.32 $6.99 | ▼ −4.51% | ▼ −10.32% | $3.80 (−48.16%) |
Apr 15, 2026 24w ago | 8-K | $7.32 $6.99 | ▼ −4.51% | ▼ −10.32% | $3.80 (−48.16%) |
Mar 26, 2026 27w ago | Press Release | $6.20 $7.18 | ▲ +15.81% | ▲ +5.14% | $3.80 (−38.79%) |
Feb 26, 2026 31w ago | 8-K | $15.36 $6.20 | ▼ −59.64% | ▼ −53.23% | $3.80 (−75.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access